Xenetic Biosciences Inc. (NASDAQ: XBIO)
$4.28
+0.2000 ( +4.90% ) 12.2K
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
Market Data
Open
$4.28
Previous close
$4.08
Volume
12.2K
Market cap
$6.46M
Day range
$4.05 - $4.33
52 week range
$2.87 - $5.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 08, 2023 |
ars | Annual reports | 1 | Nov 13, 2023 |
def | Proxies and info statements | 15 | Nov 13, 2023 |
8-k | 8K-related | 15 | Nov 13, 2023 |
10-q | Quarterly Reports | 47 | Nov 09, 2023 |
8-k | 8K-related | 15 | Aug 11, 2023 |
10-q | Quarterly Reports | 48 | Aug 10, 2023 |